DecisionMap Wealth Management’s Medtronic MDT Stock Holding History

DecisionMap Wealth Management’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$444K	Buy	5,676 +267	+5%	+$21.5K	0.25%	84
2026 Q1	$469K	Sell	5,409 -448	-8%	-$42.9K	0.3%	81
2025 Q4	$563K	Sell	5,857 -81	-1%	-$7.87K	0.35%	74
2025 Q3	$566K	Sell	5,938 -349	-6%	-$32.1K	0.36%	72
2025 Q2	$548K	Buy	6,287 +180	+3%	+$15.3K	0.38%	75
2025 Q1	$549K	Buy	6,107 +174	+3%	+$15.6K	0.42%	67
2024 Q4	$474K	Buy	+5,933	New	+$514K	0.38%	73

Other funds holding MDT

LMFP

Larry Mathis Financial Planning Phoenix, Arizona $124B AUM

FWIA

Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return

Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Gradient Investments Arden Hills, Minnesota $7.25B AUM 20.71% 1-Year Est. Return

MAA

Matrix Asset Advisors White Plains, New York $1.23B AUM 26.4% 1-Year Est. Return

CGH

Crossmark Global Holdings Houston, Texas $7.71B AUM 37.66% 1-Year Est. Return

CNB

Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return

DecisionMap Wealth Management's MDT Position: Q2 2026 in Review

DecisionMap Wealth Management increased its Medtronic (MDT) stake by 4.9% in Q2 2026, buying an estimated $21.5K and bringing the position to 5,676 shares worth $444K. The position accounts for 0.25% of the portfolio, ranked #84.

DecisionMap Wealth Management first reported a position in MDT in Q4 2024 and has held it in 7 quarters since. The position peaked at $566K in Q3 2025. 479 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

DecisionMap Wealth Management held 5,676 shares of Medtronic worth $444K as of Q2 2026.
DecisionMap Wealth Management bought 267 Medtronic shares in Q2 2026, an estimated $21.5K.
Medtronic made up 0.25% of DecisionMap Wealth Management's portfolio in Q2 2026, its #84 holding.
DecisionMap Wealth Management first reported a position in Medtronic in Q4 2024 and has held it in 7 quarters since.
DecisionMap Wealth Management's Medtronic position peaked at $566K in Q3 2025.
479 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on DecisionMap Wealth Management's 13F filing for Q2 2026, filed 21 Jul 2026.